tirzepatide 10 mg 0.5 ml 10mg/mL New Tirzepatide Access and Pricing

Tirzepatide (Generic Mounjaro): A dual GLP-1 and GIP receptor agonist, FDA-approved for type 2 diabetes and used off-label for weight loss

Mounjaro may also not be suitable for people with- History of pancreatitis Diabetic retinopathy Kidney problems Upcoming surgeries Digestive issues like gastroparesis Pregnancy or breastfeeding plans Known allergies to the drug or its ingredients The medication carries a "boxed warning" from the FDA, making it essential for patients to discuss their medical history with their healthcare provider before starting treatment

But walking is

Clean the BAC water stopper with an alcohol swab before each draw and use a fresh syringe for each vial

The active drug is well studied, but a compounded product is not FDA-reviewed, so quality depends on the pharmacy

Supplies Needed Plan based on an 816 week protocol with gradual titration (onceweekly dosing)